Metallo-β-lactamases in the age of multidrug resistance: from structure and mechanism to evolution, dissemination, and inhibitor design

G Bahr, LJ Gonzalez, AJ Vila - Chemical Reviews, 2021 - ACS Publications
Antimicrobial resistance is one of the major problems in current practical medicine. The
spread of genes coding for resistance determinants among bacteria challenges the use of …

[HTML][HTML] β-Lactamases and β-Lactamase Inhibitors in the 21st Century

CL Tooke, P Hinchliffe, EC Bragginton… - Journal of molecular …, 2019 - Elsevier
The β-lactams retain a central place in the antibacterial armamentarium. In Gram-negative
bacteria, β-lactamase enzymes that hydrolyze the amide bond of the four-membered β …

NDM metallo-β-lactamases and their bacterial producers in health care settings

W Wu, Y Feng, G Tang, F Qiao… - Clinical microbiology …, 2019 - Am Soc Microbiol
New Delhi metallo-β-lactamase (NDM) is a metallo-β-lactamase able to hydrolyze almost all
β-lactams. Twenty-four NDM variants have been identified in> 60 species of 11 bacterial …

β-lactam Resistance in Pseudomonas aeruginosa: Current Status, Future Prospects

KA Glen, IL Lamont - Pathogens, 2021 - mdpi.com
Pseudomonas aeruginosa is a major opportunistic pathogen, causing a wide range of acute
and chronic infections. β-lactam antibiotics including penicillins, carbapenems …

VNRX-5133 (Taniborbactam), a Broad-Spectrum Inhibitor of Serine- and Metallo-β-Lactamases, Restores Activity of Cefepime in Enterobacterales and Pseudomonas …

JC Hamrick, JD Docquier, T Uehara… - Antimicrobial Agents …, 2020 - Am Soc Microbiol
As shifts in the epidemiology of β-lactamase-mediated resistance continue, carbapenem-
resistant Enterobacterales (CRE) and carbapenem-resistant Pseudomonas aeruginosa …

Carbapenemases: Transforming Acinetobacter baumannii into a Yet More Dangerous Menace

MS Ramirez, RA Bonomo, ME Tolmasky - Biomolecules, 2020 - mdpi.com
Acinetobacter baumannii is a common cause of serious nosocomial infections. Although
community-acquired infections are observed, the vast majority occur in people with …

New carbapenemase inhibitors: clearing the way for the β-lactams

JC Vázquez-Ucha, J Arca-Suárez, G Bou… - International Journal of …, 2020 - mdpi.com
Carbapenem resistance is a major global health problem that seriously compromises the
treatment of infections caused by nosocomial pathogens. Resistance to carbapenems …

Imitation of β-lactam binding enables broad-spectrum metallo-β-lactamase inhibitors

J Brem, T Panduwawala, JU Hansen, J Hewitt… - Nature Chemistry, 2022 - nature.com
Carbapenems are vital antibiotics, but their efficacy is increasingly compromised by metallo-
β-lactamases (MBLs). Here we report the discovery and optimization of potent broad …

The antimicrobial peptide thanatin disrupts the bacterial outer membrane and inactivates the NDM-1 metallo-β-lactamase

B Ma, C Fang, L Lu, M Wang, X Xue, Y Zhou… - Nature …, 2019 - nature.com
New Delhi metallo-β-lactamase-1 (NDM-1) is the most prevalent type of metallo-β-lactamase
and hydrolyzes almost all clinically used β-lactam antibiotics. Here we show that the …

β-lactam antibiotics and β-lactamase enzymes inhibitors, part 2: our limited resources

S Alfei, AM Schito - Pharmaceuticals, 2022 - mdpi.com
β-lactam antibiotics (BLAs) are crucial molecules among antibacterial drugs, but the
increasing emergence of resistance to them, developed by bacteria producing β-lactamase …